Stocks to sell

Home Depot (HD) — Lower spending on non-essential household items could be in the offing. In addition, the stock’s price multiples are sky high, which is a rarity for mature companies. Tesla (TSLA) — Cyclicality could catch up with Tesla. Its vehicles are “best-in-class”. However, economic throughs have previously shown to impact most discretionary companies. Visa
0 Comments
Rivian (RIVN) is facing macroeconomic and geopolitical headwinds The IPO lock-up expires in May, allowing early investors to sell their shares Investors should stay away from RIVN stock until further updates are provided on fundamentals Source: Miro Vrlik Photography / Shutterstock.com Rivian’s (NASDAQ:RIVN) fall from grace is a hard pill to swallow for its investors.
0 Comments
Camber Energy (CEI) says it’s a carbon capture play It’s a failing oil driller, backed by tweets and a short squeeze Please don’t buy it unless you like to lose money Source: OlegRi / Shutterstock Camber Energy (NYSEAMERICAN:CEI) stock is not and likely never will be an investment. It’s a dream, backed by stock, that
0 Comments
Novavax (NASDAQ:NVAX) stock has seen a big plunge from all-time highs of $277. The downtrend seems unabated with NVAX stock trading almost 6% lower in today’s trade. A surge in cases related to omicron subvariant BA.2 is an indication of the point that the pandemic is far from over. However, NVAX stock has not responded
0 Comments
Tesla’s (NASDAQ:TSLA) Austin gigafactory Factory will benefit stock prices. But Tesla’s most productive factory now sits idle due to Covid-19 precautions. Hawkish news out of the Federal Reserve doesn’t benefit growth plays including Tesla. Source: Grisha Bruev / Shutterstock.com Tesla (NASDAQ:TSLA) is battling a lot of production issues currently. As a result, the stock could
0 Comments
Newegg (NASDAQ:NEGG) stock has important strengths and key weaknesses. Newegg — an e-commerce company that focuses on tech — is a profitable, rapidly growing company in an expanding, very promising sector. But on the other hand, it appears to be a meme stock and has become linked to cryptocurrencies at a time when meme stocks
0 Comments
Biogen’s (BIIB) Aduhelm looks like a market failure Approvals on treatments that don’t cure are now under challenge There can be no unlimited draw from a limited pool of funds Source: PictureDesignSwiss / Shutterstock.com When Biogen (NASDAQ:BIIB) stock got its Alzheimer’s drug Aduhelm approved last June, the stock spiked to nearly $420/share. It was due
0 Comments
Today’s price action in the broader market is certainly something most investors don’t want to see. The three major indices are solid red, with most major growth stocks getting hit hard today. Investors in SoFi Technologies (NASDAQ:SOFI) and SOFI stock have not been spared. In fact, SOFI stock hit a fresh new 52-week low today, trading as low
0 Comments